TSX · Drug Manufacturers - Specialty & Generic · CAD
Charlotte's Web Holdings, Inc. (CWEB.TO) Stock Analysis
Charlotte's Web Holdings, Inc. (CWEB.TO) is a Drug Manufacturers - Specialty & Generic stock listed on TSX and quoted in Canadian Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CWEB.TO Key Statistics
As of Oct 21, 2026Trading
- Open
- CA$0.36
- Previous Close
- CA$0.34
- Day's Range
- 0.35–0.36
- 52-Week Range
- 0.11–1.33
- Volume
- 3.50K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 2.25
Valuation
- Market Cap
- CA$94.95M
- P/E Ratio
- unprofitable
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 25.59
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 2.03
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −0.29
Financials (FY)
- Revenue (FY)
- CA$49.90M+0.46%
- Net Income (FY)
- −CA$29.74M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −73.61%
- Shares Outstanding
- 271.29M
- 1-Year Return
- +40.00%
Dividend and dates
- Earnings Date
- November 11, 2026estimated
- Avg Volume
- 62.41K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, CWEB.TO closed at CA$0.35, +40.00% over 1 year.
Charlotte's Web Holdings, Inc. (CWEB.TO) has a market capitalization of CA$94.95M.
In fiscal 2025, CWEB.TO reported revenue of CA$49.90M.
CWEB.TO Stock Return by Calendar Year
Charlotte's Web Holdings, Inc. (CWEB.TO) return since Sep 2018: what CA$10,000 became
- 1 year
- CA$10,000 CA$14,000
- +40.00%
- 5 years
- CA$10,000 CA$1,440
- −85.60%
- Since Sep 2018
- CA$10,000 CA$242
- −97.58%
If you had invested CA$10,000 in Charlotte's Web Holdings, Inc. (CWEB.TO) at the close on September 13, 2018, the earliest close on record here, it would have been worth CA$242 at the close on October 21, 2026: −97.58% in total, −36.81% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −30.00% |
| 2025 | +284.62% |
| 2024 | −51.85% |
| 2023 | −63.01% |
| 2022 | −42.97% |
| 2021 | −69.45% |
| 2020 | −57.85% |
| 2019 | −34.48% |
| 2018 (partial year) | +4.98% |
As of October 21, 2026.
CWEB.TO Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | CA$49.90M | −CA$29.74M | −59.6% |
| 2024 | CA$49.67M | −CA$29.85M | −60.1% |
| 2023 | CA$63.16M | −CA$23.80M | −37.7% |
| 2022 | CA$74.14M | −CA$59.31M | −80.0% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | CA$49.90M | CA$21.70M | −CA$20.27M | −CA$29.74M | −59.6% |
| 2024 | CA$49.67M | CA$21.26M | −CA$31.99M | −CA$29.85M | −60.1% |
| 2023 | CA$63.16M | CA$35.57M | −CA$40.06M | −CA$23.80M | −37.7% |
| 2022 | CA$74.14M | CA$19.41M | −CA$50.65M | −CA$59.31M | −80.0% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
CWEB.TO Valuation vs Drug Manufacturers - Specialty & Generic Median
Median of 97 stocks| Metric | CWEB.TO | Drug Manufacturers - Specialty & Generic median | vs median |
|---|---|---|---|
| P/S ratio | 2.03 | 2.10 | 3% below |
| Profit margin | −73.61% | −8.14% | 65.5 pts below |
Medians across 97 Drug Manufacturers - Specialty & Generic stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Drug Manufacturers - Specialty & Generic Stocks
Takeda Pharmaceutical Company Limited
$63.67B
TEVATeva Pharmaceutical Industries Limited
$47.37B
HLNHaleon plc
$44.06B
ZTSZoetis Inc.
$32.90B
UTHRUnited Therapeutics Corporation
$24.17B
VTRSViatris Inc.
$21.19B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B